Variant report
Variant | esv3337977 |
---|---|
Chromosome Location | chr4:187904852-187927155 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-FAT1-1 | chr4:187917410-187917592 | XLOC_004215 |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs559531998 | chr4:187904861-187904862 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527766978 | chr4:187904901-187904902 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs190198884 | chr4:187904913-187904914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs571435323 | chr4:187904919-187904920 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs567984104 | chr4:187904974-187904975 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs150223426 | chr4:187904982-187904983 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs145431526 | chr4:187905016-187905017 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs114549767 | chr4:187905021-187905022 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs71607934 | chr4:187905043-187905044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs115603521 | chr4:187905076-187905077 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs149217770 | chr4:187905098-187905099 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs78429533 | chr4:187905111-187905112 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs368928965 | chr4:187905112-187905113 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs534815558 | chr4:187905116-187905117 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs373856457 | chr4:187905143-187905144 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs114759482 | chr4:187905144-187905145 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
17 | rs535393738 | chr4:187905162-187905163 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs183146463 | chr4:187905183-187905184 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs543606660 | chr4:187905198-187905199 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs186873000 | chr4:187905202-187905203 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs35164948 | chr4:187905203-187905204 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs192039299 | chr4:187905215-187905216 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs553913709 | chr4:187905216-187905217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs113813601 | chr4:187905227-187905228 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs559411607 | chr4:187905241-187905242 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs146879336 | chr4:187905273-187905274 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs545134559 | chr4:187905330-187905331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs4574464 | chr4:187905342-187905343 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
29 | rs1425962 | chr4:187905399-187905400 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
30 | rs574492915 | chr4:187905410-187905411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs546982346 | chr4:187905412-187905413 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs571897097 | chr4:187905447-187905448 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs567583116 | chr4:187905496-187905497 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs539385373 | chr4:187905512-187905513 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs4487413 | chr4:187905516-187905517 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs13142305 | chr4:187905533-187905534 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
37 | rs565755998 | chr4:187905555-187905556 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs534661029 | chr4:187905568-187905569 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs187636077 | chr4:187905596-187905597 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs147879327 | chr4:187905629-187905630 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs28712664 | chr4:187905630-187905631 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs557257876 | chr4:187905648-187905649 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs569897142 | chr4:187905687-187905688 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs58751088 | chr4:187905688-187905689 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs574256588 | chr4:187905724-187905725 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs191111269 | chr4:187905739-187905740 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs553662305 | chr4:187905744-187905745 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs59577673 | chr4:187905747-187905748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs182196735 | chr4:187905754-187905755 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs187166887 | chr4:187905797-187905798 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Breast cancer | 16608533 | CNVD |
Wilms tumour | 21544195 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 16272173 | CNVD |
Breast cancer | 17133270 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Breast cancer | 21785460 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
small cell lung cancer | 20016488 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Breast cancer | 21633010 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Cancer | 20581869 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
abnormal development | 18461090 | CNVD |
Neuroblastoma | 16790693 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Congenital anomalies of the kidney and urinary tract | 18316590 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Facioscapulohumeral muscular dystrophy | 21829175 | CNVD |
Disorders of sex development | 21048976 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Autism | 18414403 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Cancer | 20164920 | CNVD |
Cancer | 20164919 | CNVD |
Breast cancer | 20409316 | CNVD |
Rhabdomyosarcoma | 16790082 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Schizophrenia | 21399695 | CNVD |
Developmental delay | 22127048 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Cervical cancer | 21063398 | CNVD |
Oral cancer | 21386901 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Oral cancer | 17325662 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:187901800-187905000 | Weak transcription | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
2 | chr4:187902600-187905400 | Weak transcription | Ganglion Eminence derived primary cultured neurospheres | brain |
3 | chr4:187904000-187906600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
4 | chr4:187904000-187909000 | Weak transcription | Aorta | Aorta |
5 | chr4:187904800-187906200 | Enhancers | Cortex derived primary cultured neurospheres | brain |
6 | chr4:187905000-187906000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
7 | chr4:187905400-187906200 | Enhancers | Ganglion Eminence derived primary cultured neurospheres | brain |
8 | chr4:187911800-187942600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
9 | chr4:187919800-187920000 | Enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
10 | chr4:187920800-187921200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
11 | chr4:187920800-187921200 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
12 | chr4:187920800-187921200 | Enhancers | NHLF | lung |
13 | chr4:187920800-187921400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
14 | chr4:187924000-187925400 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
15 | chr4:187925400-187927000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
16 | chr4:187926000-187928200 | Enhancers | Fetal Kidney | kidney |
17 | chr4:187926400-187927800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
18 | chr4:187926400-187928200 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
19 | chr4:187927000-187927400 | Enhancers | HMEC | breast |
20 | chr4:187927000-187927800 | Enhancers | Fetal Stomach | stomach |
21 | chr4:187927000-187928200 | Enhancers | Breast Myoepithelial Primary Cells | Breast |
22 | chr4:187927000-187928200 | Enhancers | Fetal Lung | lung |
23 | chr4:187927000-187928400 | Enhancers | NHEK | skin |
24 | chr4:187927000-187928800 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |